News & Events

May 4, 2021

BrainsWay Announces Social Media Sweepstakes to Celebrate Mental Health Awareness Month

The Sweepstakes, demonstrating how Deep Transcranial Magnetic Stimulation (Deep TMS) can fit into an...

May 3, 2021

BrainsWay to Ring NASDAQ Closing Bell to Highlight May as Mental Health Awareness Month

CRESSKILL, N.J. and JERUSALEM, May 03, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE: BWAY)...

April 29, 2021

BrainsWay Announces Launch of Noninvasive Treatment for Smoking Addiction to U.S. Providers

Patients in areas across the country now have access to Deep Transcranial Magnetic Stimulation (Deep...

April 26, 2021

BrainsWay Receives FDA Clearance for Three-Minute Theta Burst Treatment Protocol for Major Depressive Disorder

Shorter Protocol Further Expands Access to Care CRESSKILL, N.J. and JERUSALEM, April 26, 2021 (GLOBE...

April 14, 2021

BrainsWay Announces 100,000 Patients Treated with Deep Transcranial Magnetic Stimulation (Deep TMS)

The FDA cleared technology is a noninvasive treatment for depression, OCD, and smoking addiction CRESSKILL,...

March 24, 2021

BrainsWay Reports Fourth Quarter and Full-Year 2020 Financial Results and Operational Highlights

Conference call to be held tomorrow, March 25, 2021, at 8:30 AM ET CRESSKILL, N.J. and JERUSALEM, Israel,...

March 11, 2021

BrainsWay to Report Fourth Quarter and Full Year 2020 Financial Results on March 25, 2021

CRESSKILL, N.J., March 11, 2020 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the...

March 8, 2021

BrainsWay to Present at the Oppenheimer 31st Annual Healthcare Conference

CRESSKILL, N.J. and JERUSALEM, Israel, March 8, 2021 – BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay”...

February 23, 2021

BrainsWay Ltd. Announces Pricing of $39,287,000 Underwritten Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 23, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 22, 2021

BrainsWay Ltd. Announces Proposed Public Offering of American Depositary Shares

CRESSKILL, N.J. and JERUSALEM, Feb. 22, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ & TASE:...

February 16, 2021

BrainsWay Enhances Commercial Leadership Team with the Addition of Fran Hackett as Vice President of North American Sales

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

February 16, 2021

BrainsWay Reports Preliminary Record Fourth Quarter Revenue and Full-Year 2020 Financial Results

CRESSKILL, N.J. and JERUSALEM, Israel, February 16, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

January 25, 2021

BrainsWay Signs Exclusive Distribution Agreement with Gaelan Medical Trade LLC

CRESSKILL, N.J. and JERUSALEM, Israel, Jan. 25, 2021 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 18, 2020

BrainsWay Reports Third Quarter 2020 Financial Results and Operational Highlights

CRESSKILL, N.J. and JERUSALEM, Israel, November 18, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...

November 11, 2020

BrainsWay Announces Publication of New Real-World OCD Data for its Deep TMS System in Journal of Psychiatric Research

Additional data on first non-invasive medical device cleared by the FDA for OCD demonstrated that 73%...

November 4, 2020

BrainsWay to Report Third Quarter 2020 Financial Results and Operational Highlights on November 18, 2020

CRESSKILL, N.J. and JERUSALEM, Israel, November 4, 2020 (GLOBE NEWSWIRE) – BrainsWay Ltd. (NASDAQ...